Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
Bogdahn, U., Hau, P., Stockhammer, G., Venkataramana, N.K., Mahapatra, A.K., Suri, A., Balasubramaniam, A., Nair, S., Oliushine, V., Parfenov, V., Poverennova, I., Zaaroor, M., Jachimczak, P., Ludwig, S., Schmaus, S., Heinrichs, H., Schlingensiepen, K.-H.
Published in Neuro-oncology (Charlottesville, Va.) (01.01.2011)
Published in Neuro-oncology (Charlottesville, Va.) (01.01.2011)
Get full text
Journal Article
Trabedersen (AP 12009) in the treatment of patients with advanced tumors: Completion of dose-escalation and first efficacy data
Oettle, H., Hilbig, A., Seufferlein, T., Luger, T., Schmid, R. M., von Wichert, G., Schmaus, S., Heinrichs, H., Schlingensiepen, K.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Phase I/II study with trabedersen (AP 12009) monotherapy for the treatment of patients with advanced pancreatic cancer, malignant melanoma, and colorectal carcinoma
Oettle, H., Hilbig, A., Seufferlein, T., Tsianakas, A., Luger, T., Schmid, R. M., von Wichert, G., Endlicher, E., Garbe, C., Kaehler, K. K., Hauschild, A., Enk, A., Kiessling, P., Schmaus, S., Heinrichs, H., Schlingensiepen, K.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Interim results of the phase I/II study of trabedersen (AP 12009) in patients with pancreatic carcinoma, malignant melanoma, or colorectal carcinoma
Oettle, H., Hilbig, A., Seufferlein, T., Schmid, R. M., Luger, T., von Wichert, G., Schmaus, S., Heinrichs, H., Schlingensiepen, K.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
Bogdahn, U., Hau, P., Stockhammer, G., Venkataramana, N. K., Mahapatra, A. K., Suri, A., Balasubramaniam, A., Nair, S., Oliushine, V., Parfenov, V., Poverennova, I., Zaaroor, M., Jachimczak, P., Ludwig, S., Schmaus, S., Heinrichs, H., Schlingensiepen, K.- H.
Published in Neuro-oncology (Charlottesville, Va.) (01.01.2011)
Published in Neuro-oncology (Charlottesville, Va.) (01.01.2011)
Get full text
Journal Article
Preliminary results of a phase I/II study in pancreatic carcinoma, malignant melanoma, and colorectal carcinoma with the TGF- β2 inhibitor AP 12009
Oettle, H., Seufferlein, T., Schmid, R., Luger, T., Ludwig, S., Schmaus, S., Wuerth, G., Heinrichs, H., Schlingensiepen, K.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Preliminary results of a phase I/II study in patients with pancreatic carcinoma, malignant melanoma, or colorectal carcinoma using systemic i.v. administration of AP 12009
Hilbig, A., Seufferlein, T., Schmid, R. M., Luger, T., Oettle, H., Schneider, G., Schmaus, S., Wuerth, G., Heinrichs, H., Schlingensiepen, K. H.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Targeted tumor therapy with the TGF-beta2 antisense compound AP 12009 for the treatment of advanced solid tumors
Oettle, H., Seufferlein, T., Schmid, R., Luger, T., Ludwig, S., Schmaus, S., Beyer, M., Fischer, D., Hafner, M., Schlingensiepen, K.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Targeted down regulation of TGF-beta2 in pancreatic carcinoma: A phase I/II dose escalation study to evaluate the safety and tolerability of the antisense oligonucleotide AP 12009
Schlingensiepen, K.-H., Bischof, A., Egger, T., Hafner, M., Herrmuth, H., Kielmanowicz, M., Ludwig, S., Schmaus, S., Stauder, G.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
Spatial Inhomogeneity of the Superconducting Gap and Order Parameter in FeSe_{0.4}Te_{0.6}
Singh, U R, White, S C, Schmaus, S, Tsurkan, V, Loidl, A, Deisenhofer, J, Wahl, P
Published in arXiv.org (20.08.2013)
Published in arXiv.org (20.08.2013)
Get full text
Paper
Journal Article
TGF-beta2 suppression by the antisense oligonucleotide AP 12009 as therapy for high-grade glioma: safety and efficacy results of phase I/II clinical studies
Hau, P, Bogdahn, U, Brawanski, A, Freudenstein, D, Goldbrunner, M, Grisold, W, Hundsberger, T, Koch, D, Kostron, H, Kunst, M, Mehdorn, M, Meixensberger, J, Pichler, J, Schackert, G, Schlaier, J, Schlingensiepen, R, Schmaus, S, Schneider, T, Spitznagel, L, Stauder, G, Stockhammer, G, Wassmann, H, Weller, M, Winking, M, Wurm, G, Schlingensiepen, KH
Published in Aktuelle Neurologie (07.09.2004)
Published in Aktuelle Neurologie (07.09.2004)
Get full text
Conference Proceeding
Spintronics with single molecules
Wulfhekel, W., Miyamachi, T., Schmaus, S., Yamada, T. K., Takacs, A. F., Bagrets, A., Evers, F., Balashov, T., Gruber, M., Davesne, V., Bowen, M., Beaurepaire, E.
Published in 2012 12th IEEE International Conference on Nanotechnology (IEEE-NANO) (01.08.2012)
Published in 2012 12th IEEE International Conference on Nanotechnology (IEEE-NANO) (01.08.2012)
Get full text
Conference Proceeding
Nonequilibrium Cotunneling through a Three-Level Quantum Dot
Schmaus, S, Koerting, V, Paaske, J, Jespersen, T S, Nygård, J, Wölfle, P
Published in arXiv.org (09.01.2009)
Published in arXiv.org (09.01.2009)
Get full text
Paper
Journal Article